Orthofix Medical Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 184.01 million compared to USD 114 million a year ago. Net loss was USD 28.86 million compared to USD 10.72 million a year ago. Basic loss per share from continuing operations was USD 0.77 compared to USD 0.53 a year ago. Diluted loss per share from continuing operations was USD 0.77 compared to USD 0.53 a year ago.
For the nine months, sales was USD 546.23 million compared to USD 338.48 million a year ago. Net loss was USD 129.22 million compared to USD 12.69 million a year ago. Basic loss per share from continuing operations was USD 3.53 compared to USD 0.63 a year ago. Diluted loss per share from continuing operations was USD 3.53 compared to USD 0.63 a year ago.